Previous 10 | Next 10 |
2023-04-12 10:03:10 ET Gainers: Altamira Therapeutics ( CYTO ) +74% . Arrowhead Pharmaceuticals ( ARWR ) +11% . Procaps Group ( PROC ) +11% . Tempest Therapeutics ( TPST ) +11% . Meihua International Medical Technologies ( MHUA )...
2023-04-12 02:57:39 ET Clinical-stage biopharmaceutical company developing anti-inflammatory therapeutics by targeting the complement system,InflaRx N.V. ( NASDAQ: IFRX ) priced its underwritten public offering of ~9.42M shares at an offering price of $4.25 per share. ...
JENA, Germany, April 12, 2023 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX) (the “Company”), a clinical-stage biopharmaceutical company developing anti-inflammatory therapeutics by targeting the complement system, announced today the pricing of its underwritten public offering of ...
2023-04-11 16:23:04 ET Shares of German biotech InflaRx N.V. ( NASDAQ: IFRX ) held steady in the post-market trading even after the company announced the launch of an underwritten public offering of its ordinary shares. The company said the offering is subject to market and ot...
JENA, Germany, April 11, 2023 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX) (the “Company”), a clinical-stage biopharmaceutical company developing anti-inflammatory therapeutics by targeting the complement system, announced today that it has commenced an underwritten public offeri...
2023-04-10 08:55:07 ET OncoSec Medical ( ONCS ) +65%.GlucoTrack ( GCTK ) +29%.Guardforce AI ( GFAI ) +22%.Eloxx Pharmaceuticals ( ELOX ) +15%.Cocrystal Pharma ( COCP ) +13% on completing $4 Million private placement priced at-the-market under Nasdaq rules.Enlivex Therape...
2023-04-10 08:33:38 ET Summary InflaRx's Gohibic received Emergency Use Authorization (EUA) from the US FDA for treating severe COVID-19 cases. Gohibic, an anti-C5a monoclonal antibody, may reduce mortality rates and the need for renal replacement therapy in COVID-19 patients. ...
2023-04-07 10:21:36 ET InflaRx (NASDAQ: IFRX) stock soared this week on news that one of the company's treatments for COVID-19 had received Emergency Use Authorization (EUA) from the Food and Drug Administration (FDA). The company's share price closed out the shortened trading week ...
2023-04-06 13:25:31 ET Gainers: Guardforce AI ( GFAI ) +61% . Amesite ( AMST ) +31% . Tellurian ( TELL ) +29% . The Singing Machine Company ( MICS ) +27% . Cardlytics ( CDLX ) +22% . Finance Of America Companies ( FOA ) ...
2023-04-06 08:23:15 ET Lumentum Holdings ( LITE ) -14% on lowering Q3 expectations. Scilex Holding Company ( SCLX ) -13% a nnounces p ostponement of annual meeting of stockholders. AMC Entertainment Holdings ( APE ) -12% as court rules against c...
News, Short Squeeze, Breakout and More Instantly...
JENA, Germany, June 24, 2024 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, announced today that GOHIBIC (vilobelimab) has been selected by the Biomedical Advanced Research and Development ...
Thought leaders in complement inhibition, chronic spontaneous urticaria (CSU) and hidradenitis suppurativa (HS) provide compelling new insights into the strong development rationales, potential differentiation and medical role of INF904 in initially targeted indications and inflammation & imm...
JENA, Germany, May 21, 2024 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, announced data presented at the American Thoracic Society (ATS) 2024 International Conference that is being held f...